Jupiter Research Capital (Asia) Ltd’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$292K Buy
+4,821
New +$338K 0.03% 497
2026
Q2
– Sell
-4,363
Closed -$314K – 998
2026
Q1
$314K Buy
+4,363
New +$248K 0.03% 502

Other funds holding NKTR

Jupiter Research Capital (Asia) Ltd's NKTR Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 4,821 shares worth $292K. The stake represents 0.03% of the portfolio and ranks #497 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in NKTR as recently as Q1 2026.

Jupiter Research Capital (Asia) Ltd first reported a position in NKTR in Q1 2026 and has held it in 2 quarters since. The position peaked at $314K in Q1 2026. 235 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 4,821 shares of Nektar Therapeutics worth $292K as of Q3 2026.
  • Nektar Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Nektar Therapeutics made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #497 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Nektar Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Jupiter Research Capital (Asia) Ltd's Nektar Therapeutics position peaked at $314K in Q1 2026.
  • 235 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.